HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Bovi Selected Research

COVID-19

11/2021Stroke management during the coronavirus disease 2019 (COVID-19) pandemic: experience from three regions of the north east of Italy (Veneto, Friuli-Venezia-Giulia, Trentino-Alto-Adige).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Bovi Research Topics

Disease

37Stroke (Strokes)
06/2023 - 09/2011
31Ischemic Stroke
10/2023 - 01/2011
17Atrial Fibrillation
04/2021 - 01/2012
11Hemorrhage
01/2020 - 02/2013
5Cerebral Hemorrhage
01/2021 - 09/2011
5Embolic Stroke
01/2019 - 01/2012
3Heart Failure
04/2021 - 01/2012
3Brain Ischemia (Cerebral Ischemia)
01/2019 - 04/2014
3Embolism (Embolus)
10/2018 - 10/2011
2Hyperlipidemias (Hyperlipidemia)
04/2021 - 01/2012
2Leukoaraiosis
06/2019 - 01/2019
2Hypertension (High Blood Pressure)
06/2019 - 01/2012
2Blood Vessel Dissection
10/2017 - 12/2011
2Patent Foramen Ovale
08/2017 - 01/2016
2Myocardial Infarction
03/2015 - 04/2014
1COVID-19
11/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2021
1Dementia (Dementias)
04/2021
1Hemorrhagic Stroke
10/2018
1Hyperglycemia
03/2018
1Hyperthermia
03/2018
1Infarction (Infarctions)
01/2018
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2017
1Infections
09/2017
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2015
1Purpura
01/2015
1Migraine with Aura (Familial Hemiplegic Migraine)
04/2014
1Lacunar Stroke
01/2014
1Hemorrhagic Disorders (Hemorrhagic Diathesis)
02/2013
1Neoplasms (Cancer)
02/2013
1Diabetes Mellitus
01/2012
1Amaurosis Fugax
10/2011
1Paresis (Hemiparesis)
10/2011
1Migraine Disorders (Migraine)
01/2011
1Parkinson Disease (Parkinson's Disease)
02/2006

Drug/Important Bio-Agent (IBA)

18AnticoagulantsIBA
04/2021 - 02/2013
9Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 01/2012
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016 - 09/2011
4Vitamin KFDA Link
12/2020 - 11/2017
4Metalloproteases (Metalloproteinases)IBA
01/2019 - 10/2013
44- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
01/2018 - 01/2012
3DabigatranFDA Link
04/2021 - 05/2017
3Matrix Metalloproteinases (MMPs)IBA
01/2019 - 10/2013
3Blood Glucose (Blood Sugar)IBA
09/2018 - 01/2012
2Biomarkers (Surrogate Marker)IBA
06/2019 - 01/2011
2apixabanIBA
11/2017 - 09/2017
2CholesterolIBA
01/2016 - 01/2012
2Prothrombin (Factor II)IBA
03/2015 - 01/2011
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2019
1von Willebrand FactorIBA
06/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2019
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2019
1SmokeIBA
06/2019
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2019
1Particulate MatterIBA
09/2018
1ORALIT (ORS)IBA
03/2018
13-O-(2'-acetoxy)benzoyl-2-glucopyranoseIBA
01/2018
1Clopidogrel (Plavix)FDA Link
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
1RivaroxabanIBA
11/2017
1Amyloidogenic ProteinsIBA
09/2017
1idarucizumabIBA
05/2017
1Warfarin (Coumadin)FDA LinkGeneric
10/2016
1Factor V (Coagulation Factor V)IBA
03/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
03/2015
1Dihydrotachysterol (AT 10)IBA
04/2014
1Antiphospholipid AntibodiesIBA
04/2014
1Antihypertensive Agents (Antihypertensives)IBA
04/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2011
1Transforming Growth Factor-beta Type II ReceptorIBA
12/2011
1Transforming Growth Factor-beta Type I ReceptorIBA
12/2011
1Retinaldehyde (Retinal)IBA
10/2011
1factor V LeidenIBA
01/2011
1Antipsychotic Agents (Antipsychotics)IBA
02/2006

Therapy/Procedure

14Therapeutics
10/2023 - 06/2012
8Secondary Prevention
02/2020 - 10/2014
6Thrombectomy
06/2023 - 08/2017
2Thrombolytic Therapy
01/2020 - 01/2012
1Time-to-Treatment
01/2021
1Aftercare (After-Treatment)
01/2019
1Endovascular Procedures
10/2014
1Activities of Daily Living (ADL)
01/2012